Download Literature - Precision Clinical Trial Solutions

NGS Biomarker Discovery

Foundation Medicine will work with your company to perform comprehensive genomic profiling of patient samples in our CLIA-certified and CAP-accredited laboratory.  The unmatched sensitivity and accuracy of our next-generation sequencing platform provides clinical-grade results appropriate for both biomarker discovery and clinical applications.  Foundation Medicine will characterize your clinical trial and research samples utilizing our portfolio of clinical diagnostic tests: FoundationOne®, FoundationOne Heme and/or FoundationACT™.

Research and Data Analysis

Utilizing your outcomes data, Foundation Medicine supports prospective enrollment screening, retrospective analyses, as well as other sponsor-initiated research studies.  Foundation Medicine offers expert followup analysis of the genomic data we generate, including de novo biomarker signature discovery.

Clinical Trial Patient Matching

Foundation Medicine is reinventing oncology clinical research by dramatically increasing patient access to investigational agents and trials.

Foundation Medicine's Precision Enrollment Services contacts physicians whose patients are ideally suited to participate in your clinical trial, providing up-to-date information on the investigational agent and ways to entoll.

Foundation Medicine partners with specialty CROs to enable Just in Time trial site initiation, ensuring every eligible patient is able to enroll in a sponsor's trial.

 

Please fill out this form to access the brochure.